marketing production

Digital

Overview View our webinar which took place on Tuesday 23rd July at 16:00 BST / 11:00 EST / 08:00 PST.

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.